One of the gurus of liver disease here who specializes in liver failure mentions that if ibuprofen, aspirin, or tylenol were new drugs that applied for FDA permission to be marketed likely all 3 would be rejected due to their toxicities either in overdose or in normal dosing. I think that he is right.
|